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Twenty-six scientists from 10 countries met
at the International Agency for Research on
Cancer (IARC) in June 2004 to develop
IARC Monographs on the Evaluation of the
Carcinogenic Risk of Chemicals to Humans
(IARC Monographs) on formaldehyde,
2-butoxyethanol, and 1-tert-butoxy-2-
propanol (IARC, in press). This is the fourth
IARC evaluation of formaldehyde and the
ﬁrst of the glycol ethers.
Formaldehyde is widely used in resins that
bind wood products, pulp and paper, and
glasswool and rockwool insulation. It is also
used in plastics and coatings, textile ﬁnishing,
and chemical manufacturing and as a disinfec-
tant and preservative. High concentrations can
be found in some work environments, and
much lower concentrations in homes.
2-Butoxyethanol is a glycol ether widely
used as a solvent in paints, paint thinners,
glass-cleaning and surface-cleaning products
(especially in the printing and silk-screening
industries), and personal-care and other per-
sonal products and as a chemical intermedi-
ate. General-population exposure can occur
through the use of consumer products, partic-
ularly cleaning agents.
1-tert-Butoxy-2-propanol is a glycol ether
that has found increasing use as a solvent in
coatings, glass-cleaning and surface-cleaning
products, inks, adhesives, and nail-polish
lacquers.
Materials and Methods
IARC convenes an international, interdis-
ciplinary working group of expert scientists to
develop each volume of the IARC Monographs.
The working group writes a critical review of
the pertinent scientific literature (published
articles, articles accepted for publication, and
publicly available documents from government
agencies) and a consensus evaluation of each
agent’s potential to cause cancer in humans.
The IARC Monographs are developed dur-
ing an 8-day meeting whose objectives are
review and consensus. Before the meeting, each
member of the working group writes a portion
of the critical review. At the meeting, four sub-
groups (exposure, cancer in humans, cancer in
experimental animals, and mechanistic and
other relevant data) review these drafts and
develop consensus subgroup drafts. Then the
working group meets in plenary session to
review the subgroup drafts and develop a con-
sensus evaluation. After the meeting, IARC sci-
entists review the ﬁnal draft for accuracy and
clarity before publication.
The evaluation is developed in steps (IARC
2005). The subgroup of epidemiologists pro-
poses an evaluation of the evidence of cancer in
humans as sufﬁcient evidence, limited evidence,
inadequate evidence, or evidence suggesting
lack of carcinogenicity. A subgroup of toxicolo-
gists and pathologists proposes an evaluation
of the evidence of cancer in experimental ani-
mals, choosing one of the same descriptors.
Combination of these two partial evaluations
yields a preliminary default evaluation that the
agent is one of the following: group 1, car-
cinogenic to humans; group 2A, probably car-
cinogenic to humans; group 2B, possibly
carcinogenic to humans; group 3, not classiﬁ-
able as to its carcinogenicity to humans; or
group 4, probably not carcinogenic to humans.
When the epidemiologic evidence is sufﬁ-
cient, the final evaluation is carcinogenic to
humans, regardless of the experimental evi-
dence. In other cases, the mechanistic and
other relevant data are considered to deter-
mine whether the default evaluation should be
modified upward or downward. A subgroup
of experts in cancer mechanisms assesses the
strength of the mechanistic data and whether
the mechanisms of tumor formation in experi-
mental animals can operate in humans. The
overall evaluation is a matter of scientiﬁc judg-
ment, reﬂecting the combined weight of the
evidence.
Working groups are selected to invite the
best-qualified experts and to avoid real or
apparent conﬂicts of interests. Consideration
is given also to demographic diversity and
a balanced representation of all scientific
views. Each potential participant submits
a Declaration of Interests [World Health
Organization (WHO) 2005], which IARC
assesses to determine whether there is a con-
ﬂict that warrants some limitation on partici-
pation. An expert with a real or apparent
conflict of interest may not serve as chair-
person, draft text discussing cancer data, or
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An international, interdisciplinary working group of expert scientists met in June 2004 to develop
IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans (IARC
Monographs) on formaldehyde, 2-butoxyethanol, and 1-tert-butoxy-2-propanol. Each IARC
Monograph includes a critical review of the pertinent scientiﬁc literature and an evaluation of an
agent’s potential to cause cancer in humans. After a thorough discussion of the epidemiologic,
experimental, and other relevant data, the working group concluded that formaldehyde is carcino-
genic to humans, based on sufﬁcient evidence in humans and in experimental animals. In the epi-
demiologic studies, there was sufﬁcient evidence that formaldehyde causes nasopharyngeal cancer,
“strong but not sufficient” evidence of leukemia, and limited evidence of sinonasal cancer. The
working group also concluded that 2-butoxyethanol and 1-tert-butoxy-2-propanol are not classiﬁ-
able as to their carcinogenicity to humans, each having limited evidence in experimental animals
and inadequate evidence in humans. These three evaluations and the supporting data will be-
published as Volume 88 of the IARC Monographs. Key words: 1-tert-butoxy-2-propanol,
2-butoxyethanol, carcinogen, formaldehyde, glycol ethers, hazard identiﬁcation, IARC Monographs,
leukemia, nasopharyngeal cancer, sinonasal cancer. Environ Health Perspect 113:1205–1208
(2005). doi:10.1289/ehp.7542 available via http://dx.doi.org/ [Online 12 May 2005]
Researchparticipate in the evaluations. IARC strives to
ensure that the working group is free from all
attempts at interference, before and during
the meeting. This includes lobbying, written
materials, and meals or other favors offered by
interested parties. Working group members
are asked not to discuss the subject matter
with anyone outside the meeting and to
report all attempts at interference (Cogliano
et al. 2004).
Results
Formaldehyde. There was a statistically signiﬁ-
cant excess of deaths from nasopharyngeal can-
cer in the largest and most informative cohort
study of industrial workers (Hauptmann et al.
2004), with statistically signiﬁcant exposure–
response relationships for peak and cumulative
exposure. An excess of deaths from nasopha-
ryngeal cancer was also observed in a propor-
tionate mortality analysis of the largest U.S.
cohort of embalmers (Hayes et al. 1990), and
an excess of cases of nasopharyngeal cancer was
observed in a Danish study of proportionate
cancer incidence among workers at companies
that manufactured or used formaldehyde
(Hansen and Olsen 1995). Although other
cohort studies reported fewer cases of nasopha-
ryngeal cancer than expected (Coggon et al.
2003; Pinkerton et al. 2004; Walrath and
Fraumeni 1983), the working group noted
that the deﬁcits were small and the studies had
low power to detect an effect on nasopharyn-
geal cancer. Of seven case–control studies of
nasopharyngeal cancer (Armstrong et al. 2000;
Hildesheim et al. 2001; Olsen et al. 1984;
Roush et al. 1987; Vaughan et al. 1986, 2000;
West et al. 1993), ﬁve found elevations of risk
for exposure to formaldehyde. The working
group considered it “improbable that all of the
positive findings for nasopharyngeal cancer
that were reported from the epidemiologic
studies, and particularly from the large study of
industrial workers in the United States, could
be explained by bias or unrecognized con-
founding effects.” The working group con-
cluded that these studies provide “sufficient
epidemiological evidence that formaldehyde
causes nasopharyngeal cancer in humans.”
Excess mortality from leukemia, primarily of
the myeloid type, has been observed relatively
consistently in six of seven studies of embalmers,
funeral parlor workers, pathologists, and
anatomists (Hall et al. 1991; Hayes et al. 1990;
Levine et al. 1984; Logue et al. 1986; Stroup
et al. 1986; Walrath and Fraumeni 1983,
1984). A recent meta-analysis found that, over-
all, the relative risk for leukemia in these workers
was increased and did not vary significantly
among studies (Collins and Lineker 2004).
There had been speculation that these ﬁndings
might be explained by viruses; however, the
working group found little evidence that these
occupations have a higher incidence of viral
infections or that viruses have a causal role
in myeloid leukemia. Until recently, these
leukemia findings received little attention
because excess leukemia had not been observed
in the studies of industrial workers. There is
now, however, some evidence for an association
between formaldehyde exposure and leukemia
in the recent updates of two of the three major
industrial cohorts. A statistically significant
exposure–response relationship was observed
for leukemia and, particularly, for myeloid
leukemia in the study of industrial workers in
the United States, based on peak exposure and,
to a lesser degree, on average intensity of expo-
sure to formaldehyde (Hauptmann et al. 2003).
There was no excess mortality from
leukemia when the industrial workers were
compared with the general U.S. population,
but a comparison with the general population
may be biased. In another study, excess mor-
tality from leukemia was found in the recent
update of garment workers in the United
States (Pinkerton et al. 2004). This excess was
statistically signiﬁcant among workers with a
longer duration of exposure and follow-up. In
contrast, the updated study of industrial work-
ers in the United Kingdom did not ﬁnd excess
mortality from leukemia (Coggon et al. 2003).
This high-quality study had sufﬁcient size and
follow-up to have reasonable power for detect-
ing an excess of leukemia, but it did not report
on peak exposures or the risk of myeloid
leukemia speciﬁcally. The working group con-
cluded, “In summary, there is strong but not
sufficient evidence for a causal association
between leukaemia and occupational exposure
to formaldehyde.” This conclusion, falling
between sufﬁcient and limited evidence, was
based on a consistently increased risk in stud-
ies of embalmers, funeral parlor workers,
pathologists, and anatomists and was present
in two of the three most informative studies of
industrial workers.
Several case–control studies have investi-
gated the relationship between formaldehyde
exposure and sinonasal cancer. A pooled analy-
sis of 12 studies showed an increased risk of
adenocarcinoma in men and women thought
never to have been exposed to wood dust or
leather dust, with an exposure–response trend
for an index of cumulative exposure (Luce
et al. 2002). One other case–control study
(Olsen and Asnaes 1986) and a proportionate
incidence study (Hansen and Olsen 1995)
showed an increased risk of sinonasal cancer,
particularly squamous cell carcinoma. Against
these largely positive ﬁndings, the three most
informative cohort studies of industrial work-
ers showed no excesses of sinonasal cancer
(Coggon et al. 2003; Hauptmann et al. 2004;
Pinkerton et al. 2004). The working group
noted that most studies did not distinguish
tumors as originating in the nose or sinuses;
thus, an increased risk of nasal cancer would be
diluted if there were no corresponding effect
on the sinuses. In the case–control studies, the
working group also noted the potential for
confounding by wood dust exposure, which is
associated with adenocarcinoma. The working
group concluded that there is limited evidence
that formaldehyde causes sinonasal cancer in
humans.
In experimental animals, several studies
have shown that inhalation exposure induces
squamous cell carcinomas of the nasal cavities
in rats (Albert et al. 1982; Feron et al. 1988;
Gibson 1984; Kamata et al. 1997; Kerns et al.
1983; Monticello et al. 1996; Morgan et al.
1986; Sellakumar et al. 1985; Woutersen et al.
1989), although single studies in mice (Kerns
et al. 1983) and hamsters (Dalbey 1982)
showed no carcinogenic effects. Four studies of
formaldehyde administered to rats in drinking
water gave varying results: One showed an
increased incidence of forestomach papillomas
in male rats (Takahashi et al. 1986); a second
showed an increased incidence of gastrointesti-
nal leiomyosarcomas in female rats and in
both sexes combined (Soffritti et al. 1989); a
third showed increased incidences of total
malignant tumors, lymphomas and leukemias,
and testicular interstitial-cell adenomas in
male rats (Soffritti et al. 2002); whereas a
fourth did not show a carcinogenic effect (Til
et al. 1989). Formaldehyde also showed co-
carcinogenic effects by inhalation, ingestion,
and dermal exposure (Dalbey 1982; Iverson
1986; Takahashi et al. 1986).
The toxicokinetics of inhaled formalde-
hyde have been well studied (Agency for
Toxic Substances and Disease Registry 1999).
More than 90% of inhaled formaldehyde is
absorbed in the upper respiratory tract (Heck
et al. 1985). Absorbed formaldehyde can be
oxidized to formate and carbon dioxide or
can be incorporated into biologic macro-
molecules. Formaldehyde has a half-life of
about 1 min in rat plasma (Rietbrock 1965).
Inhalation exposure has not been found to
alter the endogenous concentration of for-
maldehyde in the blood of rats, monkeys, or
humans (Casanova et al. 1988; Heck et al.
1983, 1985). Oral exposure to 14C-formalde-
hyde resulted in some excretion in urine and
feces within 12 hr (Galli et al. 1983). Dermal
application of 14C-formaldehyde resulted in
some urinary excretion in rats and monkeys
(Jeffcoat et al. 1983).
Evidence shows that formaldehyde is
genotoxic in multiple in vitro models and in
exposed humans and laboratory animals.
Human studies reported increased DNA–
protein crosslinks in workers exposed to
formaldehyde (Shaham et al. 1996, 2003),
and this is consistent with studies in lab-
oratory rats and monkeys. Cellular prolifera-
tion increases considerably at concentrations
> 6 ppm and ampliﬁes the genotoxic effects of
Cogliano et al.
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“The current data indicate that both genotoxi-
city and cytotoxicity play important roles in
the carcinogenesis of formaldehyde in nasal tis-
sues.” On the other hand, with respect to the
potential for formaldehyde to induce leukemia,
the working group was not aware of any good
rodent models for acute myeloid leukemia in
humans. Several possible mechanisms were
considered, such as clastogenic damage to cir-
culating stem cells. There is a single study
reporting cytogenetic abnormalities in the
bone marrow of rats inhaling formaldehyde
(Kitaeva et al. 1990). The working group con-
cluded, “Based on the data available at this
time, it was not possible to identify a mecha-
nism for the induction of myeloid leukaemia
in humans.” This is an area needing more
research.
The working group concluded that
formaldehyde is carcinogenic to humans
(group 1), based on sufficient evidence in
humans and sufﬁcient evidence in experimen-
tal animals. Based on the information now
available, this classification is higher than
those of previous IARC evaluations (IARC
1982, 1987, 1995).
2-Butoxyethanol. 2-Butoxyethanol was
tested for carcinogenicity by inhalation expo-
sure in male and female mice and rats
[National Toxicology Program (NTP) 2000].
Clear increases in tumor incidence were
observed only in mice. In male mice exposed
to 2-butoxyethanol, there was a dose-related
increase in the incidence of hemangiosarco-
mas of the liver. In female mice, there was a
dose-related increase in the incidences of
combined forestomach squamous-cell papillo-
mas and carcinomas (mainly papillomas). In
female rats, there was a positive trend in the
occurrence of benign or malignant pheochro-
mocytomas (mainly benign) of the adrenal
medulla, but this equivocal result could not
be attributed with conﬁdence to exposure to
2-butoxyethanol. No increases were observed
in male rats. The epidemiologic data were
inadequate for this compound.
Regarding mechanisms of carcinogenesis,
the working group considered that hemolysis
and associated oxidative stress in the liver
have been proposed to be linked to the induc-
tion of mouse liver neoplasia. They also con-
sidered that, in view of lower sensitivity to
hemolysis of human erythrocytes and higher
human liver concentrations of the antioxidant
vitamin E, the induction of liver tumors in
humans would be improbable through this
pathway, but it was noted that other potential
mechanisms have not been investigated. The
working group observed that the mouse
forestomach tumors are associated with high
local exposure to 2-butoxyethanol and high
local concentrations of the toxic metabolite
2-butoxyacetic acid.
The working group concluded that
2-butoxyethanol is not classifiable as to its
carcinogenicity to humans (group 3), with
limited evidence in experimental animals and
inadequate evidence in humans.
1-tert-Butoxy-2-propanol. 1-tert-Butoxy-
2-propanol was tested for carcinogenicity by
inhalation exposure in male and female mice
and rats (Doi et al. 2004; NTP 2003). In a sin-
gle study in both male and female mice, a
dose-related increase in the combined inci-
dence of liver tumors (hepatocellular adenomas
and carcinomas), including hepatoblastomas,
was observed. When hepatocellular carcinomas
and hepatoblastomas were combined, there
was a significant trend for the increase in
malignant tumors in females. In male rats,
there were marginal, nonsigniﬁcant increases in
the incidences of renal tubule adenomas (with
one carcinoma at the highest dose) and hepato-
cellular adenomas, but these ﬁndings were con-
sidered to be equivocal. In female rats, there
were no dose-related increases in tumor inci-
dence. No epidemiologic data were available
for this compound.
With regard to mechanisms of carcino-
genesis, the working group found the avail-
able data inadequate to elucidate a potential
mechanism for the mouse liver tumors. They
found the renal effects largely consistent with
the α2u-globulin–associated nephropathy that
occurs in male rats, but concluded that the
available evidence satisﬁes only some, but not
all, of the IARC criteria for the mechanism
associated with accumulation of α2u-globulin.
Regarding the potential for genotoxic effects,
the working group was not able to draw any
meaningful conclusion in view of the scarcity
of the data available.
The working group concluded that 1-tert-
butoxy-2-propanol is not classiﬁable as to its
carcinogenicity to humans (group 3), with
limited evidence in experimental animals and
inadequate evidence in humans.
Discussion
A theme common to these three evaluations is
the consideration of mechanistic information
to develop and evaluate hypotheses about the
sequence of steps leading to the induction of
tumors in experimental animals. The hypothe-
sized mechanisms described in these evalua-
tions provide an interesting set of cases that
range from a vast literature on respiratory-tract
tumors in rats induced by inhalation of for-
maldehyde to some more tentative hypotheses
about the various tumors observed in animals
after exposure to glycol ethers. Both types of
mechanistic data sets were of use in the evalua-
tion process.
The evaluation of formaldehyde as carcino-
genic to humans shows the importance of
mechanistic information in the classiﬁcation of
carcinogens. For the nasopharyngeal tumors,
the working group discussed the convergence
of the epidemiologic, experimental, and mech-
anistic evidence. If the evidence in humans had
been less than sufﬁcient, the strong mechanis-
tic evidence in exposed humans and sufﬁcient
evidence in experimental animals might still
have led to classiﬁcation as group 1. The exten-
sive mechanistic data for formaldehyde-induced
respiratory cancer provide strong support for
the empirical observation of nasopharyngeal
cancer in humans, although computer models
that predict an anterior-to-posterior gradient of
formaldehyde deposition in the upper respira-
tory tract would predict that formaldehyde
would cause cancer in the nose as well as the
nasopharynx in humans.
On the other hand, the lack of information
on possible mechanisms by which formalde-
hyde might increase the risk of leukemia in
humans tempered the interpretation of the
epidemiologic data on that cancer type. The
entire working group discussed at length
this divergence between the epidemiologic
and mechanistic conclusions for leukemia.
Information to support a biologically plausible
mechanism could have supported a stronger
conclusion about the evidence of leukemia in
humans.
In the evaluations of the glycol ethers,
the working group grappled with questions
of interpretation and scientific judgment. A
recurring issue was the criterion for character-
izing a rare tumor or an unusual set of obser-
vations that can carry greater weight than a
typical bioassay result. A related matter was
how to bring in additional information to
resolve difﬁcult questions—for example, how
to consider the results of historical controls or
alternative statistical tests. When the working
group tried to, but could not, reach consensus
on a question of interpretation or scientific
judgment, the evaluation presented the differ-
ing positions favored by its members. For
example, after thorough discussion, several
members of the working group favored an
evaluation of the carcinogenicity in experi-
mental animals as sufﬁcient for 1-tert-butoxy-
2-propanol. This view emphasized the dose-
related induction of hepatoblastoma in male
and female mice, considering hepatoblastoma
as a rare neoplasm with low spontaneous inci-
dence in mice, especially in females. Most of
the working group, nevertheless, considered
the evidence to be limited, based on the inter-
pretation of hepatoblastoma being a variant of
hepatocellular carcinoma.
It is important to note that the evaluation
of an agent as not classiﬁable as to its carcino-
genicity to humans is not a determination of
safety, with respect to both cancer and effects
other than cancer. It indicates that the data
did not meet the minimum standards devel-
oped by the IARC for sufficient evidence in
experimental animals and suggests that further
IARC Monographs on formaldehyde and glycol ethers
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widespread human exposure or another reason
for public health concern.
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